Brief: Bavarian Nordic Wins Contract Options In US For Freeze-dried Smallpox/Mpox Vaccines
06/05/2025 08:14
May 6 (Reuters) - Bavarian Nordic A/S BAVA.CO: AWARDED CONTRACT OPTIONS FROM THE U.S. GOVERNMENT FOR PRODUCTION AND SUPPLY OF FREEZE-DRIED SMALLPOX/MPOX VACCINES EXERCISED OPTIONS TOTAL USD 143.6 MILLION SECURES MANUFACTURING AND SUPPLY OF FREEZE-DRIED JYNNEOS® TO U.S. IN 2026 FINANCIAL GUIDANCE FOR 2025 REMAINS UNCHANGED BARDA EXERCISED ADDITIONAL OPTIONS VALUED AT USD 143.6 MILLION UNDER EXISTING CONTRACT Source text: ID:nGNEVkHVx Further company coverage: BAVA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Gets Smallpox/Mpox Vaccine Supply Contract
Brief: Bavarian Nordic Secures Additional Government Contract For The Supply Of Smallpox/Mpox Vaccine
Brief: Bavarian Nordic Launches Final Tranche Of Buy-Back Program
Bavarian Nordic falls as high costs, lower vaccine sales hit Q1 results
Bavarian Nordic Q1 revenue falls as Public Preparedness unit sales decline